Annual EBITDA
$4.27B$480.00M+12.67%
Summary
- Current Value
- As of today, CME annual EBITDA is $4.27B, up +12.67% on
- Historical Performance
- CME annual EBITDA is up +40.84% over the past 3 years, and up +38.88% over the past 5 years
- All-Time High Comparison
- CME annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CME annual EBITDA is +26.34% above its 3-year low of $3.38B reached on an earlier date
- Sector Comparison
- CME annual EBITDA is higher than 91.56% of companies in Financial Services sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.27B | +12.7% | +40.8% | +38.9% | +133.2% | |
| Quarterly EBITDA | $1.06B | -4.8% | +27.3% | +64.1% | +107.5% | |
| TTM EBITDA | $4.49B | +7.2% | +34.2% | +42.3% | +119.8% | |
| Price | $264.98 | +15.6% | +50.0% | +31.5% | +320.7% | |
| PE Ratio | 25.69 | +8.4% | +7.5% | -25.1% | +16.8% | |
| Annual Revenue | $6.13B | +9.9% | +30.7% | +25.6% | +136.5% | |
| Annual EPS | $9.67 | +9.2% | +32.6% | +63.7% | +289.7% | |
| Annual EBIT | $3.93B | +14.4% | +48.6% | +51.2% | +149.0% | |
| Annual Net Income | $3.53B | +9.3% | +33.9% | +66.8% | +327.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.27B | at high | |
| 5Y | $4.27B | at high | |
| All | $4.27B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.38B | N/A | +26.3% |
| 5Y | $3.03B | +40.8% | |
| All | $25.41M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of CME?
As of today, CME annual EBITDA is $4.27B
What is 1-year change in CME annual EBITDA?
CME annual EBITDA is up +12.67% year-over-year
What is 3-year change in CME annual EBITDA?
CME annual EBITDA is up +40.84% over the past 3 years
How far is CME annual EBITDA from its all-time high?
CME annual EBITDA is currently at its all-time high
How does CME annual EBITDA rank versus sector peers?
CME annual EBITDA is higher than 91.56% of companies in Financial Services sector
When is CME next annual earnings release?
The next annual earnings release for CME is on
Quarterly EBITDA
$1.06B$157.50M-12.99%
Summary
- Current Value
- As of today, CME quarterly EBITDA is $1.06B, down -12.99% on
- Historical Performance
- CME quarterly EBITDA is down -4.77% year-over-year, and up +27.32% over the past 3 years
- All-Time High Comparison
- CME quarterly EBITDA is currently -12.99% below its historical high of $1.21B set on
- 3-Year Low Comparison
- CME quarterly EBITDA is +39.04% above its 3-year low of $758.90M reached on an earlier date
- Sector Comparison
- CME quarterly EBITDA is higher than 93.76% of companies in Financial Services sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.06B | -13.0% | -4.8% | +27.3% | +64.1% | |
| Annual EBITDA | $4.27B | – | +12.7% | +40.8% | +38.9% | |
| TTM EBITDA | $4.49B | -1.2% | +7.2% | +34.2% | +42.3% | |
| Price | $264.98 | -2.4% | +15.6% | +50.0% | +31.5% | |
| PE Ratio | 25.69 | -2.4% | +8.4% | +7.5% | -25.1% | |
| Quarterly Revenue | $1.54B | -9.1% | -3.0% | +25.2% | +42.3% | |
| Quarterly EPS | $2.49 | -11.4% | -0.6% | +33.2% | +116.7% | |
| Quarterly EBIT | $972.60M | -13.9% | -5.0% | +31.6% | +85.3% | |
| Quarterly Net Income | $902.30M | -11.4% | -0.5% | +33.5% | +119.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.21B | -13.0% | |
| 3Y | $1.21B | -13.0% | |
| 5Y | $1.21B | -13.0% | |
| All | $1.21B | -13.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.03B | N/A | +2.4% |
| 3Y | $758.90M | N/A | +39.0% |
| 5Y | $635.50M | N/A | +66.0% |
| All | $33.24M | +3074.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CME?
As of today, CME quarterly EBITDA is $1.06B
What is CME quarterly EBITDA most recent change?
CME quarterly EBITDA was down -12.99% on September 30, 2025
What is 1-year change in CME quarterly EBITDA?
CME quarterly EBITDA is down -4.77% year-over-year
How far is CME quarterly EBITDA from its all-time high?
CME quarterly EBITDA is currently -12.99% below its historical high of $1.21B set on June 30, 2025
How does CME quarterly EBITDA rank versus sector peers?
CME quarterly EBITDA is higher than 93.76% of companies in Financial Services sector
When is CME next earnings release?
The next earnings release for CME is on
TTM EBITDA
$4.49B$52.90M-1.16%
Summary
- Current Value
- As of today, CME TTM EBITDA is $4.49B, down -1.16% on
- Historical Performance
- CME TTM EBITDA is up +7.20% year-over-year, and up +34.17% over the past 3 years
- All-Time High Comparison
- CME TTM EBITDA is currently -1.16% below its historical high of $4.54B set on
- 3-Year Low Comparison
- CME TTM EBITDA is +32.87% above its 3-year low of $3.38B reached on an earlier date
- Sector Comparison
- CME TTM EBITDA is higher than 94.56% of companies in Financial Services sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.49B | -1.2% | +7.2% | +34.2% | +42.3% | |
| Annual EBITDA | $4.27B | – | +12.7% | +40.8% | +38.9% | |
| Quarterly EBITDA | $1.06B | -13.0% | -4.8% | +27.3% | +64.1% | |
| Price | $264.98 | -2.4% | +15.6% | +50.0% | +31.5% | |
| PE Ratio | 25.69 | -2.4% | +8.4% | +7.5% | -25.1% | |
| TTM Revenue | $6.40B | -0.7% | +5.8% | +29.0% | +29.9% | |
| TTM EPS | $10.32 | -0.2% | +8.5% | +40.4% | +71.9% | |
| TTM EBIT | $4.16B | -1.2% | +8.0% | +39.5% | +54.2% | |
| TTM Net Income | $3.77B | -0.1% | +8.6% | +41.9% | +75.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.54B | -1.2% | |
| 3Y | $4.54B | -1.2% | |
| 5Y | $4.54B | -1.2% | |
| All | $4.54B | -1.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.27B | N/A | +5.2% |
| 3Y | $3.38B | N/A | +32.9% |
| 5Y | $2.85B | +57.4% | |
| All | $33.24M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CME?
As of today, CME TTM EBITDA is $4.49B
What is CME TTM EBITDA most recent change?
CME TTM EBITDA was down -1.16% on September 30, 2025
What is 1-year change in CME TTM EBITDA?
CME TTM EBITDA is up +7.20% year-over-year
How far is CME TTM EBITDA from its all-time high?
CME TTM EBITDA is currently -1.16% below its historical high of $4.54B set on June 30, 2025
How does CME TTM EBITDA rank versus sector peers?
CME TTM EBITDA is higher than 94.56% of companies in Financial Services sector
When is CME next earnings release?
The next earnings release for CME is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CME Official Website www.cmegroup.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm
- CME Profile on Yahoo Finance finance.yahoo.com/quote/CME
- CME Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cme